Short Interest in Fortress Biotech, Inc. (NASDAQ:FBIOP) Drops By 56.6%

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a significant drop in short interest in June. As of June 15th, there was short interest totaling 4,938 shares, a drop of 56.6% from the May 31st total of 11,366 shares. Based on an average trading volume of 41,576 shares, the days-to-cover ratio is currently 0.1 days.

Fortress Biotech Trading Up 0.6%

Fortress Biotech stock traded up $0.12 during mid-day trading on Wednesday, hitting $20.22. The company had a trading volume of 20,276 shares, compared to its average volume of 23,930. Fortress Biotech has a 12-month low of $6.27 and a 12-month high of $21.43. The company’s fifty day moving average is $17.44 and its 200-day moving average is $13.93.

Fortress Biotech Company Profile

Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.

The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.